Effects of Kampo medicine Hochuekkito on fatigue and health-related quality of life in hemodialysis patients with chronic kidney disease: a pilot study
Not Applicable
Recruiting
- Conditions
- Chronic kidney disease stage G5D
- Registration Number
- JPRN-UMIN000044853
- Lead Sponsor
- Fukushima Medical University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1. Pregnant or possibly pregnant 2. A history of allergies to hochuekkito 3. Severe hypertension (>= 180/110 mmHg) 4. Onset of cardiovascular disease within 1 month 5. Severe complications including blood disorders, active malignancies, infectious diseases, thyroid disorders, and depression 6. Using steroids, immunosuppressants (e.g. cyclosporine), and glycyrrhizin 7. Using other Kampo medicines 8. Participating in another clinical trial 9. Participants who are judged to be inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method